author-photo

Douglas J. Schwartzentruber

5

Papers

181

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

A Mosaic Activating Mutation inAKT1Associated with the Proteus Syndrome

2011 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (0)
The Use of Polyethylene Glycol-Modified Interleukin-2 (PEG-IL-2) in the Treatment of Patients with Metastatic Renal Cell Carcinoma and Melanoma A Phase I Study and a Randomized Prospective Study Comparing IL-2 Alone versus IL-2 Combined with PEG-IL-2

1995 Cancer
Show All
- Source
- Cite
- Save
Citations (69)
The Use of Polyethylene Glycol-Modified Interleukin-2 (PEG-IL-2) in the Treatment of Patients with Metastatic Renal Cell Carcinoma and Melanoma A Phase I Study and a Randomized Prospective Study Comparing IL-2 Alone versus IL-2 Combined with PEG-IL-2

1995 Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Cardiopulmonary toxicity of treatment with high dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal cell carcinoma.

1994 Cancer
Show All
- Source
- Cite
- Save
Citations (95)
In vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapy.

1993 Current Opinion in Oncology
- Douglas J. Schwartzentruber
Show All
- Source
- Cite
- Save
Citations (17)